The value of C-reactive protein in pre-clinical and clinical research is well established, and our species-specific CRP kits have a proven track record in important areas such as autoimmune and cardiovascular diseases, nutrition and toxicology research and a growing field of new applications. These specialized kits are also adapted for investigational work involving urine and other body fluids and tissues as well as culture supernatants. Please ask for our assistance in developing special protocols (modification of existing kits or novel assays) that can expand your research goals and enable you to discover additional dimensions to your findings. Package inserts, product brochure, and published literature are always available by request: info@helica.com.
DETECTION RANGE
C-Reactive Protein, Canine............... 3.6 - 40 ng/mL
C-Reactive Protein, Rat.................... 2.5 - 133 ng/mL
C-Reactive Protein, Human...............0.12 - 10 ng/mL
C-Reactive Protein, Mouse.................1.56 - 25 ng/mL
View our C-Reactive Protein Kits product page
View our product reviews
View our product reviews
RECENT CITATIONS WITH HELICA BIOSYSTEMS CRP KITS
Buduneli, E. et. al. Systemic Low-Dose Doxycycline and Alendronate Administration and Serum Interleukin-
1Beta, Osteocalcin, and C-Reactive Protein Levels in Rats. Journal of Periodontology 2005;76:1927-1933
Cai, X. et.al. The comparative study of Sprague-Dawley and Lewis rats in adjuvant-induced arthritis. Arch.
Pharmacol. 2006; 373:140-147
Chen, K. et. Induction of Leptin Resistance Through Direct Interaction of C-reactive Protein with Leptin.
Nature Medicine 2006;12:425 - 432 (Human CRP)
Cho W. C. et.al. Differential Expression of Proteins in Kidney, Eye, Aorta, and Serum of Diabetic and Non-
diabetic Rats. J. Cell. Biochem. 2006; 99: 256 - 268
Kalani, R., et.al. Effects of Caloric Restriction and Exercise on Age-Related, Chronic Inflammation Assessed
by C-Reactive Protein and Interleukin-6Effects of Caloric Restriction and Exercise on Age-Related, Chronic
Inflammation Assessed by C-Reactive Protein and Interleukin-6.
Journal of Gerontology: 2006; 61A: 3:211-217
Ling, S. and F. Jabali. Effect of Early Phase Adjuvant Arthritis on Hepatic P450 Enzymes and
Pharmacokinetics of Verapamil: An Alternative Approach to the Use of An Animal Model for Inflammation
for Pharmacokinetic Studies. Drug Metabolism and Disposition 2005; 33:579-586
Ortiz, R. et. al. Urinary C-Reactive Protein Excretion Increases in Angiotensin II-Dependent Hypertensive
Rats. FASEB Journal 2006; 20: 470.16
Shagdarsuren, E. et al. Complement Activation in Angiotensin II-Induced Organ Damage. Circ Res. 2005;
97:716-724
|
|
